Use and utility of endocrine multidisciplinary tumour board: an appraisal from a tertiary centre
IntroductionThe Endocrine Multidisciplinary Tumour Board (EMTB) is a specialised board for endocrine tumours, including thyroid, adrenal, and rare endocrine neoplasms. Although required by major guidelines, little is known about the current EMTB composition and working outcomes. The present study ai...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1513893/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850142250036625408 |
|---|---|
| author | Clotilde Sparano Clotilde Sparano Letizia Canu Letizia Canu Letizia Canu Letizia Canu Giuliano Perigli Roberto Santoro Silvia Pradella Giulia Grazzini Monica Mangoni Gabriele Simontacchi Benedetta Fibbi Vania Vezzosi Catia Olianti Mario Maggi Mario Maggi Luisa Petrone |
| author_facet | Clotilde Sparano Clotilde Sparano Letizia Canu Letizia Canu Letizia Canu Letizia Canu Giuliano Perigli Roberto Santoro Silvia Pradella Giulia Grazzini Monica Mangoni Gabriele Simontacchi Benedetta Fibbi Vania Vezzosi Catia Olianti Mario Maggi Mario Maggi Luisa Petrone |
| author_sort | Clotilde Sparano |
| collection | DOAJ |
| description | IntroductionThe Endocrine Multidisciplinary Tumour Board (EMTB) is a specialised board for endocrine tumours, including thyroid, adrenal, and rare endocrine neoplasms. Although required by major guidelines, little is known about the current EMTB composition and working outcomes. The present study aims to analyse the use and support provided by an experienced EMTB, highlighting the skills of this board.MethodsThis monocentric and retrospective study considered all the cases discussed (N=1038, concerning 835 patients) within the ETMB of Careggi University Hospital of Florence from January 1st, 2021, to December 31st, 2023. The queries have been standardised into five major groups. Besides treatment and follow-up indications, particular attention has been paid to the need for repeated discussions, additional indications, imaging revisions, and overall survival (OS) outcomes.ResultsThyroid and rare cancers were the most frequently represented (64% and 32%, respectively). At logistic regression analysis, the need for multiple discussions was associated with being a rare disease (p<0.001), familiar syndrome (p=0.003), or adrenal masses (p=0.005). When the query was "imaging review," external imaging was more often re-evaluated (p=0.027) due to differing results at EMTB revision, and in about 51% of these cases, further insights were requested. Compared to external control groups, Anaplastic Thyroid Carcinoma and Adrenocortical Carcinoma showed improved OS, 7.84 vs 2.46 months (p=0.049) and 51.92 vs 26.17 months (p=0.0076), respectively. From the hormonal perspective, further hormonal investigations were required in about 16% of eligible cases.ConclusionsEMTB is pivotal in managing and optimising common and rare endocrine tumour workups. |
| format | Article |
| id | doaj-art-99c42e79223740cbb07b2af655a463f0 |
| institution | OA Journals |
| issn | 1664-2392 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Endocrinology |
| spelling | doaj-art-99c42e79223740cbb07b2af655a463f02025-08-20T02:29:09ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922025-05-011610.3389/fendo.2025.15138931513893Use and utility of endocrine multidisciplinary tumour board: an appraisal from a tertiary centreClotilde Sparano0Clotilde Sparano1Letizia Canu2Letizia Canu3Letizia Canu4Letizia Canu5Giuliano Perigli6Roberto Santoro7Silvia Pradella8Giulia Grazzini9Monica Mangoni10Gabriele Simontacchi11Benedetta Fibbi12Vania Vezzosi13Catia Olianti14Mario Maggi15Mario Maggi16Luisa Petrone17Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Florence, Florence, ItalyEndocrinology Unit, Careggi University Hospital, Florence, ItalyDepartment of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Florence, Florence, ItalyEndocrinology Unit, Careggi University Hospital, Florence, ItalyCentro di Ricerca e Innovazione sulle Patologie Surrenaliche, Azienda Ospedaliero-Universitaria (AOU) Careggi, Florence, ItalyENS@T Center of Excellence, University of Florence, Florence, ItalyDepartment of Experimental and Clinical Medicine, University of Florence, Florence, ItalyHead and Neck Oncology and Robotic Surgery, Department of Experimental and Clinical Medicine, University of Florence, Florence, ItalyDepartment of Radiology, Careggi University Hospital, Florence, ItalyDepartment of Radiology, Careggi University Hospital, Florence, ItalyRadiotherapy Unit, Department of Experimental, Clinical and Biomedical Sciences, University of Florence, Florence, ItalyRadiotherapy Unit, Department of Experimental, Clinical and Biomedical Sciences, University of Florence, Florence, ItalyEndocrinology Unit, Medical-Geriatric Department, Careggi University Hospital, Florence, Italy0Department of Histopathology and Molecular Diagnostics, Careggi University Hospital, Florence, Italy1Unit of Nuclear Medicine, Department of Image Diagnostics, Careggi University Hospital, Florence, ItalyDepartment of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Florence, Florence, ItalyEndocrinology Unit, Careggi University Hospital, Florence, ItalyEndocrinology Unit, Medical-Geriatric Department, Careggi University Hospital, Florence, ItalyIntroductionThe Endocrine Multidisciplinary Tumour Board (EMTB) is a specialised board for endocrine tumours, including thyroid, adrenal, and rare endocrine neoplasms. Although required by major guidelines, little is known about the current EMTB composition and working outcomes. The present study aims to analyse the use and support provided by an experienced EMTB, highlighting the skills of this board.MethodsThis monocentric and retrospective study considered all the cases discussed (N=1038, concerning 835 patients) within the ETMB of Careggi University Hospital of Florence from January 1st, 2021, to December 31st, 2023. The queries have been standardised into five major groups. Besides treatment and follow-up indications, particular attention has been paid to the need for repeated discussions, additional indications, imaging revisions, and overall survival (OS) outcomes.ResultsThyroid and rare cancers were the most frequently represented (64% and 32%, respectively). At logistic regression analysis, the need for multiple discussions was associated with being a rare disease (p<0.001), familiar syndrome (p=0.003), or adrenal masses (p=0.005). When the query was "imaging review," external imaging was more often re-evaluated (p=0.027) due to differing results at EMTB revision, and in about 51% of these cases, further insights were requested. Compared to external control groups, Anaplastic Thyroid Carcinoma and Adrenocortical Carcinoma showed improved OS, 7.84 vs 2.46 months (p=0.049) and 51.92 vs 26.17 months (p=0.0076), respectively. From the hormonal perspective, further hormonal investigations were required in about 16% of eligible cases.ConclusionsEMTB is pivotal in managing and optimising common and rare endocrine tumour workups.https://www.frontiersin.org/articles/10.3389/fendo.2025.1513893/fullmultidisciplinary tumour boardendocrine neoplasmsthyroid neoplasmshealth carerare diseases |
| spellingShingle | Clotilde Sparano Clotilde Sparano Letizia Canu Letizia Canu Letizia Canu Letizia Canu Giuliano Perigli Roberto Santoro Silvia Pradella Giulia Grazzini Monica Mangoni Gabriele Simontacchi Benedetta Fibbi Vania Vezzosi Catia Olianti Mario Maggi Mario Maggi Luisa Petrone Use and utility of endocrine multidisciplinary tumour board: an appraisal from a tertiary centre Frontiers in Endocrinology multidisciplinary tumour board endocrine neoplasms thyroid neoplasms health care rare diseases |
| title | Use and utility of endocrine multidisciplinary tumour board: an appraisal from a tertiary centre |
| title_full | Use and utility of endocrine multidisciplinary tumour board: an appraisal from a tertiary centre |
| title_fullStr | Use and utility of endocrine multidisciplinary tumour board: an appraisal from a tertiary centre |
| title_full_unstemmed | Use and utility of endocrine multidisciplinary tumour board: an appraisal from a tertiary centre |
| title_short | Use and utility of endocrine multidisciplinary tumour board: an appraisal from a tertiary centre |
| title_sort | use and utility of endocrine multidisciplinary tumour board an appraisal from a tertiary centre |
| topic | multidisciplinary tumour board endocrine neoplasms thyroid neoplasms health care rare diseases |
| url | https://www.frontiersin.org/articles/10.3389/fendo.2025.1513893/full |
| work_keys_str_mv | AT clotildesparano useandutilityofendocrinemultidisciplinarytumourboardanappraisalfromatertiarycentre AT clotildesparano useandutilityofendocrinemultidisciplinarytumourboardanappraisalfromatertiarycentre AT letiziacanu useandutilityofendocrinemultidisciplinarytumourboardanappraisalfromatertiarycentre AT letiziacanu useandutilityofendocrinemultidisciplinarytumourboardanappraisalfromatertiarycentre AT letiziacanu useandutilityofendocrinemultidisciplinarytumourboardanappraisalfromatertiarycentre AT letiziacanu useandutilityofendocrinemultidisciplinarytumourboardanappraisalfromatertiarycentre AT giulianoperigli useandutilityofendocrinemultidisciplinarytumourboardanappraisalfromatertiarycentre AT robertosantoro useandutilityofendocrinemultidisciplinarytumourboardanappraisalfromatertiarycentre AT silviapradella useandutilityofendocrinemultidisciplinarytumourboardanappraisalfromatertiarycentre AT giuliagrazzini useandutilityofendocrinemultidisciplinarytumourboardanappraisalfromatertiarycentre AT monicamangoni useandutilityofendocrinemultidisciplinarytumourboardanappraisalfromatertiarycentre AT gabrielesimontacchi useandutilityofendocrinemultidisciplinarytumourboardanappraisalfromatertiarycentre AT benedettafibbi useandutilityofendocrinemultidisciplinarytumourboardanappraisalfromatertiarycentre AT vaniavezzosi useandutilityofendocrinemultidisciplinarytumourboardanappraisalfromatertiarycentre AT catiaolianti useandutilityofendocrinemultidisciplinarytumourboardanappraisalfromatertiarycentre AT mariomaggi useandutilityofendocrinemultidisciplinarytumourboardanappraisalfromatertiarycentre AT mariomaggi useandutilityofendocrinemultidisciplinarytumourboardanappraisalfromatertiarycentre AT luisapetrone useandutilityofendocrinemultidisciplinarytumourboardanappraisalfromatertiarycentre |